Is Nektar Therapeutics (NKTR) a Buy, Sell, or Hold?
Nektar Therapeutics
NASDAQ:NKTR
$67.17 USD
-$1.15 (-1.68%)
- Volume
- 814.75K
- Average Volume
- 1.17M
- Market Capitalization
- $1.31B
- P/E Ratio
- -7.98
- Dividend Yield
- 0.00%
- Price Target
- $151.00
- Year High
- $109.00
- Year Low
- $21.02
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $10.21
Analyst Rating
Strong Sell
1 Rating Score
UPSIDE/DOWNSIDE
-55.5% DOWNSIDE
$151.00 Price Target
UPSIDE/DOWNSIDE HIGH
-65.0% DOWNSIDE
$192.00 Price Target High
UPSIDE/DOWNSIDE LOW
-16.0% DOWNSIDE
$80.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Wedbush | Martin Fan | $80 | $81.89 | 2026-05-11 07:51 AM | -2.3% |
| Piper Sandler | Yasmeen Rahimi | $192 | $83.37 | 2026-05-08 07:07 AM | 130.3% |
| Oppenheimer | Jay Olson | $140 | $73.27 | 2026-03-13 12:39 PM | 91.1% |
| Piper Sandler | Yasmeen Rahimi | $105 | $36.35 | 2026-01-26 08:56 AM | 188.9% |
| Oppenheimer | Jay Olson | $115 | $50.43 | 2025-12-16 11:08 AM | 128.0% |